Cerebral oxygen metabolism in patients with early Parkinson's disease

Journal of the Neurological Sciences

Volumn 313, Issue 1-2, 2012, Pages 123-128

  Borghammer, Per ^a   Cumming, Paul ^b   Estergaard, Karen ^a   Gjedde, Albert ^c   Rodell, Anders ^a   Bailey, Christopher J ^d   Vafaee, Manoucher S ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

CBF; CMRO2; Energy metabolism; Normalization; Oxygen; Parkinson's disease; Positron emission tomography

Indexed keywords

ANTIPARKINSON AGENT;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN OXYGEN CONSUMPTION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARIETO-OCCIPITAL SULCUS; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SENSORIMOTOR CORTEX; SUBCORTEX; TEMPORAL CORTEX; VOXEL BASED MORPHOMETRY;

AGED; BRAIN; CEREBROVASCULAR CIRCULATION; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84855594062     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.09.010     Document Type: Article

References (39)

1. P.M. Keeney, J. Xie, R.A. Capaldi, and J.P. Bennett Jr. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled J Neurosci 26 19 May 10 2006 5256 5264 (Pubitemid 44315308)
2. R.B. Mounsey, and P. Teismann Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection Parkinsons Dis 2011 2011 617472
3. S. Kitamura, T. Ujike, S. Kuroki, S. Sakamoto, T. Soeda, and M. Iio Cerebral blood flow and oxygen metabolism in patients with Parkinson's disease No To Shinkei 40 10 Oct 1988 979 985
4. K.L. Leenders, L. Wolfson, J.M. Gibbs, R.J. Wise, R. Causon, and T. Jones The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease Brain 108 Pt 1 Mar 1985 171 191 (Pubitemid 15133833)
5. S. Takahashi, H. Tohgi, H. Yonezawa, S. Obara, and E. Yamazaki The effect of trihexyphenidyl, an anticholinergic agent, on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease J Neurol Sci 167 1 Aug 1 1999 56 61 (Pubitemid 29401971)
6. W.J. Powers, T.O. Videen, J. Markham, K.J. Black, N. Golchin, and J.S. Perlmutter Cerebral mitochondrial metabolism in early Parkinson's disease J Cereb Blood Flow Metab 28 10 Oct 2008 1754 1760
7. J.R. Patel, and G.J. Brewer Age-related changes in neuronal glucose uptake in response to glutamate and beta-amyloid J Neurosci Res 72 4 May 15 2003 527 536 (Pubitemid 36523427)
8. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 3 Mar 1992 181 184
9. P. Borghammer, M. Vafaee, K. Ostergaard, A. Rodell, C. Bailey, and P. Cumming Effect of memantine on CBF and CMRO2 in patients with early Parkinson's disease Acta Neurol Scand 117 5 May 2008 317 323 (Pubitemid 351503323)
10. C.J. Thompson, S. Kecani, and S. Boelen Evaluation of a Neck-Shield for use during neurological studies with a whole-body PET scanner IEEE Trans Nucl Sci 48 2001 1512 1517 (Pubitemid 33073829)
11. M.S. Vafaee, and A. Gjedde Spatially dissociated flow-metabolism coupling in brain activation Neuroimage 21 2 Feb 2004 507 515 (Pubitemid 38229913)
12. S. Ohta, E. Meyer, H. Fujita, D.C. Reutens, A. Evans, and A. Gjedde Cerebral [15O]water clearance in humans determined by PET: I. Theory and normal values J Cereb Blood Flow Metab 16 5 Sep 1996 765 780 (Pubitemid 26292045)
13. S. Ohta, E. Meyer, C.J. Thompson, and A. Gjedde Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen J Cereb Blood Flow Metab 12 2 Mar 1992 179 192
14. M. Ashkanian, P. Borghammer, A. Gjedde, L. Ostergaard, and M. Vafaee Improvement of brain tissue oxygenation by inhalation of carbogen Neuroscience 156 4 Oct 28 2008 932 938
15. H. Fujita, H. Kuwabara, D.C. Reutens, and A. Gjedde Oxygen consumption of cerebral cortex fails to increase during continued vibrotactile stimulation J Cereb Blood Flow Metab 19 3 Mar 1999 266 271 (Pubitemid 30026916)
16. P. Iversen, M. Sorensen, L.K. Bak, H.S. Waagepetersen, M.S. Vafaee, and P. Borghammer Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy Gastroenterology 136 3 Mar 2009 863 871
17. M. Ashkanian, A. Gjedde, K. Mouridsen, M. Vafaee, K.V. Hansen, and L. Ostergaard Carbogen inhalation increases oxygen transport to hypoperfused brain tissue in patients with occlusive carotid artery disease: increased oxygen transport to hypoperfused brain Brain Res 1304 Dec 22 2009 90 95
18. P. Borghammer, K.Y. Jonsdottir, P. Cumming, K. Ostergaard, K. Vang, and M. Ashkanian Normalization in PET group comparison studies-the importance of a valid reference region Neuroimage 40 2 Apr 1 2008 529 540
19. K.O.S. Vafaee MS, N. Sunde, A. Gjedde, E. Dupont, and P. Cumming Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson's disease during subthalamic stimulation Neuroimage 22 2 Jun 2004 966 974 (Pubitemid 38759462)
20. A.P. Zijdenbos, R. Forghani, and A.C. Evans Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis IEEE Trans Med Imaging 21 10 Oct 2002 1280 1291
21. I. Yakushev, A. Hammers, A. Fellgiebel, I. Schmidtmann, A. Scheurich, and H.G. Buchholz SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging Neuroimage 44 1 Jan 1 2009 43 50
22. P. Borghammer, J. Aanerud, and A. Gjedde Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization Neuroimage 46 4 Jul 15 2009 981 988
23. P. Borghammer, P. Cumming, J. Aanerud, and A. Gjedde Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease Neuroimage 45 2 Apr 1 2009 249 257
24. K.J. Worsley, C.H. Liao, J. Aston, V. Petre, G.H. Duncan, and F. Morales A general statistical analysis for fMRI data Neuroimage 15 1 Jan 2002 1 15 (Pubitemid 34852200)
25. K.J. Worsley, S. Marrett, P. Neelin, A.C. Vandal, K.J. Friston, and A.C. Evans A unified statistical approach for determining significant signals in images of cerebral activation Hum Brain Mapp 4 1996 58 73 (Pubitemid 26195721)
26. P. Borghammer, M. Chakravarty, K.Y. Jonsdottir, N. Sato, H. Matsuda, and K. Ito Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages Brain Struct Funct 214 4 May 2010 303 317
27. K. Asanuma, C. Tang, Y. Ma, V. Dhawan, P. Mattis, and C. Edwards Network modulation in the treatment of Parkinson's disease Brain 129 Pt 10 Oct 2006 2667 2678 (Pubitemid 44522100)
28. D. Eidelberg, J.R. Moeller, V. Dhawan, P. Spetsieris, S. Takikawa, and T. Ishikawa The metabolic topography of parkinsonism J Cereb Blood Flow Metab 14 5 Sep 1994 783 801 (Pubitemid 24266530)
29. C. Eggers, R. Hilker, L. Burghaus, B. Schumacher, and W.D. Heiss High resolution positron emission tomography demonstrates basal ganglia dysfunction in early Parkinson's disease J Neurol Sci 276 1-2 Jan 15 2009 27 30
30. N.I. Bohnen, R.A. Koeppe, S. Minoshima, B. Giordani, R.L. Albin, and K.A. Frey Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study J Nucl Med 52 6 Jun 2011 848 855
31. C. Huang, C. Tang, A. Feigin, M. Lesser, Y. Ma, and M. Pourfar Changes in network activity with the progression of Parkinson's disease Brain 130 Pt 7 Jul 2007 1834 1846 (Pubitemid 47343798)
32. M. Ghaemi, J. Raethjen, R. Hilker, J. Rudolf, J. Sobesky, and G. Deuschl Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study Mov Disord 17 4 Jul 2002 782 788 (Pubitemid 41295025)
33. Melzer TR, Watts R, Macaskill MR, Pearson JF, Rueger S, Pitcher TL, et al. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain. 2011 Feb 9;134(Pt 3)(134(Pt 3)):845-55.
34. Y. Ma, C. Tang, P.G. Spetsieris, V. Dhawan, and D. Eidelberg Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility J Cereb Blood Flow Metab 27 3 Mar 2007 597 605
35. H. Braak, K. Del Tredici, U. Rub, R.A. de Vos, E.N. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2 Mar-Apr 2003 197 211
36. H. Shimada, S. Hirano, H. Shinotoh, A. Aotsuka, K. Sato, and N. Tanaka Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET Neurology 73 4 Jul 28 2009 273 278 [Epublication ahead of print 2009 May 27]
37. M.A. Mintun, M.E. Raichle, W.R. Martin, and P. Herscovitch Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography J Nucl Med 25 2 Feb 1984 177 187 (Pubitemid 14187475)
38. M.A. Mintun, A.G. Vlassenko, G.L. Shulman, and A.Z. Snyder Time-related increase of oxygen utilization in continuously activated human visual cortex Neuroimage 16 2 Jun 2002 531 537 (Pubitemid 34852465)
39. R.S. Frackowiak, G.L. Lenzi, T. Jones, and J.D. Heather Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values J Comput Assist Tomogr 4 6 Dec 1980 727 736 (Pubitemid 11247403)